webinar register page

A Foundation Briefing on Industry AMR Surveillance: Data for Action
Join Vivli for a Foundation Briefing on Industry AMR Surveillance: Data for Action

Featuring Remarks from:
Dame Sally Davies
UK Special Envoy on Antimicrobial Resistance, UK Government; Master of Trinity College, Cambridge

Dr. Marc Mendelson
Professor of Infectious Diseases and Head of the Division of Infectious Diseases & HIV Medicine at Groote Schuur Hospital, University of Cape Town

View the list of speakers and their biographies here: https://files.constantcontact.com/f41fd375701/d5de00a8-f648-4177-b119-7461ac2c276a.pdf

View the full agenda of the meeting here:

Goals of this meeting are:
• To educate attendees about AMR and the benefits of sharing surveillance data
• To gain financial support from foundations for future sustainability of the platform
• To encourage potential data contributors to share their surveillance data on the register
• Hear from high profile speakers from government agencies and foundations invited by Wellcome and Vivli

The event will take place September 30, 2021 from 09:00-12:00 ET, 14:00-17:00 BST, 22:00-01:00 JST

Sep 30, 2021 09:00 AM in Eastern Time (US and Canada)

Webinar logo
* Required information


Featured Speaker: Dame Sally Davies
UK Special Envoy on AMR
Dame Sally Davies was appointed as the UK Government’s Special Envoy on AMR in 2019. She is also the 40th Master of Trinity College, Cambridge University. Dame Sally was Chief Medical Officer for England and Senior Medical Advisor to the UK Government from 2011-2019. She is a leading figure in global health, having served as a member of the World Health Organisation(WHO) Executive Board 2014-2016, and as co-convener of the United Nations Inter-Agency Co-ordination Group(IACG) on Antimicrobial Resistance(AMR), reporting in 2019. In November 2020, Dame Sally was announced as a member of the new UN Global Leaders Group on AMR, serving alongside Heads of State, Ministers and prominent figures from around the world to advocate for action on AMR. In the 2020 New Year Honours, Dame Sally became the second woman (and the first outside the Royal family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research, having received her DBE in 2009.
Featured Speaker: Dr. Marc Mendelson
Professor of Infectious Diseases and Head of the Division of Infectious Diseases & HIV Medicine @Groote Schuur Hospital, University of Cape Town
Dr. Mendelson is chair of the South African Ministerial Advisory Committee on Antimicrobial Resistance (AMR), and a founding, chair of the South African Antibiotic Stewardship Programme. His involvement with international policy related to AMR includes work with the World Health Organization, Global Antibiotic Research & Development Partnership, World Economic Forum, AMR Benchmark, and the Global Health Security Agenda. He is past-president of the Federation of Infectious Diseases Societies of Southern Africa and the International Society for Infectious Diseases. Dr. Mendelson studied Medicine at St Mary’s Hospital, London, and specialized in infectious diseases at Addenbrookes Hospital, Cambridge, where he attained his PhD. He moved to The Rockefeller University, New York, in 2001 and subsequently to UCT, initially to work on tuberculosis and innate immunity.
Featured Speaker: Dr. Rafael Cantón
Head of the Clinical Microbiology Department at the University Hospital Ramón y Cajal, Madrid
Dr. Cantón is Head of the Clinical Microbiology Department at the University Hospital Ramón y Cajal (Madrid, Spain), an investigator at the Ramón y Cajal Institute of Health Research and an associated Professor of Clinical Microbiology at Complutense University of Madrid, Spain. He is currently clinical data coordinator of the European Committee for Antimicrobial Susceptibility Testing (former president) and member of the advisory board of the Joint Programming Initiative on Antimicrobial Resistance. He has been President of the Spanish Society of Infectious Diseases and Clinical Microbiology, ad hoc member of the Steering Committee of the European Society for Clinical Microbiology and Infectious Disease and associated editor of Clinical Microbiology and Infection journal. He has published more than 500 articles in medical journals and 55 book chapters in the field of clinical microbiology and antimicrobial resistance. His H-factor is 70 with more than 21,000 citations.
Dr. Timothy Jinks
Head of Infectious Diseases Interventions, Wellcome Trust
Dr. Timothy Jinks is currently leading Wellcome Trust’s activities to support development of interventions against the world’s urgent infectious disease threats. He previously served for five years as Head of Drug Resistant Infections leading the strategic plan to address antimicrobial resistance. This followed a role in Wellcome’s Innovations Division, where he was responsible for a portfolio of over a dozen early-stage product development projects covering therapeutics, diagnostic and devices spanning across therapeutic areas such as infectious diseases and oncology. Prior to joining the Trust in 2012 he has over a decade of industry experience as a product developer and most recently as a consultant providing business development, licensing and commercial research services.
Dr. Nicholas Feasey
Board Chair, SEDRIC and Professor, Liverpool School of Tropical Medicine
Nick Feasey is a clinician academic and Professor of Microbiology at the Liverpool School of Tropical Medicine. He is a consultant in medical microbiology and clinical infectious disease and based at the Wellcome Asia and Africa Programme in Blantyre, Malawi, the “Malawi Liverpool Wellcome Research Programme” (MLW) His research is focused both on the surveillance and management of bacterial bloodstream infection, and takes a one health approach to exploring the transmission of enteric pathogens and associated antimicrobial resistance determinants. He leads an interdisciplinary research group in Malawi and collaborates with the Wellcome Sanger Institute and the CHICAS group at the University of Lancaster to integrate genomic and spatial statistical methods into his work.